Giannotti, Elisabetta https://orcid.org/0000-0001-6924-9822
Lambertini, Matteo
Article History
Received: 18 August 2024
Revised: 18 August 2024
Accepted: 17 September 2024
First Online: 16 October 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Elisabetta Giannotti.
: Dr. Giannotti reports speaker honoraria from Mammotome and JCA Seminar and travel support from Mammotome, EUSOBI and ESR, all outside the submitted work. Dr. Lambertini reports advisory role for Roche, Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Gilead, MSD, Exact Sciences, Pierre Fabre, Menarini; speaker honoraria from Roche, Lilly, Novartis, Pfizer, Sandoz, Libbs, Daiichi Sankyo, Takeda, Gilead, AstraZeneca, Menarini; travel Grants from Gilead, Daiichi Sankyo, Roche; research funding (to the Institution) from Gilead all outside the submitted work.
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required.
: Institutional Review Board approval was not required.
: Not applicable.
: